Business Standard

Advanced Enzyme Technologies Share Price

Know More
BSENSE

380.40-1.10 (-0.29%)

10:57 AM,23rd Apr 2024

380.00 0.20 (0.05%)

10:49 AM,23rd Apr 2024

BSE : 540025

NSE : ADVENZYMES

Sector : Health care

ISIN Code : INE837H01020

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 23-Apr-2024 | 10:57 AM IST

Market Cap (₹ Cr)

4,253

Turnover (₹ Cr)

0.03

Volume (Shares)

7,870

Face Value

2

52-WK High

425.10

52-WK High Date

15-Feb-2024

52-WK Low

252.05

52-WK Low Date

28-Apr-2023

All Time High

503.00

All Time High Date

19-May-2021

All Time Low

91.05

All Time Low Date

23-Mar-2020

Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing of enzymes by improving the fundamentals based on research and technology. The Company is engaged in the research and development manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. It has manufacturing facilities and research & development centers across India Germany and the US. Advanced Enzyme Technologies Limited (AETL) was incorporated as a Private Limited Company on March 15 1989 under the provisions of the Companies Act 1956 as 'Advanced Biochemicals Private Limited' in Maharashtra. P...
Read More

Advanced Enzyme Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Advanced Enzyme Technologies Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24200MH1989PLC051018</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+Stable</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Sanjay Basantani <br/> Designation: Company Secretary and Head Legal <br/> EmailId: sanjay@advancedenzymes.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Beni Prasad Rauka <br/> Designation: Chief Financial Officer <br/> EmailId: Brauka@advancedenzymes.com</div> </div> <div> <br/> Date: 17/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Advanced Enzyme Technologies Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

4,248

EPS - TTM (₹) [S]

10.95

P/E Ratio (X) [S]

7.64

Face Value (₹) 2
Latest Dividend (%)50.00
Latest Dividend Date 04-Aug-2023
Dividend Yield (%) 0.26
Book Value Share (₹) [S]49.71
P/B Ratio (₹) [S]7.64

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HDFC Small Cap Fund (G) 112.11 32,17,468 0.41
HDFC Small Cap Fund (IDCW) 112.11 32,17,468 0.41
HDFC Small Cap Fund - Direct (G) 112.11 32,17,468 0.41
HDFC Small Cap Fund - Direct (IDCW) 112.11 32,17,468 0.41
ICICI Pru ESG Exclusionary Strategy Fund-Reg (G) 34.86 10,00,321 2.48
ICICI Pru ESG Exclusionary Strategy Fund-Dir (G) 34.86 10,00,321 2.48
ICICI Pru P.H.D Fund - Direct (IDCW) 29.91 8,58,274 0.79
ICICI Pru P.H.D Fund - Direct (G) 29.91 8,58,274 0.79
ICICI Pru P.H.D Fund (IDCW) 29.91 8,58,274 0.79
ICICI Pru P.H.D Fund (G) 29.91 8,58,274 0.79

Load more

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

376.05

384.65

Week Low/High

349.95

384.65

Month Low/High

343.80

384.65

Year Low/High

251.00

425.00

All time Low/High

91.05

504.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week5.56%5.63%1.200.96%
1 Month6.34%6.15%1.361.19%
3 Month2.38%2.48%4.905.28%
6 Month25.29%23.36%14.3215.97%
1 Year47.43%47.86%23.7426.87%
3 Year-1.45%-1.35%54.1855.92%

Company Info

Company Information

Whole-time director : MUKUND MADHUSUDAN KABRA

Independent Director : KEDAR JAGDISH DESAI

Chairman (Non-Executive) : VASANT RATHI

Independent Director : Pramod Kasat

Company Sec. & Compli. Officer : Sanjay Basantani

Independent Director : Rajesh Kumar Sharma

Non-Exec & Non-Independent Dir : Rasika Rathi

Independent Director : Vindokumar Hiralal Jajoo

Non-Exec & Non-Independent Dir : Sunny Sharma

Independent Director : Rajshree Patel

Independent Director : NITIN JAGANNATH DESHMUKH

Independent Director : Vandana Tilak.

Registered Office: Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi,Thane,Maharashtra-400604 Ph: 91-22-41703200

Email:sanjay@advancedenzymes.com; info@advancedenzymes.c

URL:http://www.advancedenzymes.com